Previous close | 61.93 |
Open | 60.90 |
Bid | 59.59 x 1000 |
Ask | 60.20 x 800 |
Day's range | 58.59 - 61.51 |
52-week range | 34.88 - 277.80 |
Volume | |
Avg. volume | 7,222,004 |
Market cap | 4.709B |
Beta (5Y monthly) | 1.51 |
PE ratio (TTM) | N/A |
EPS (TTM) | -17.51 |
Earnings date | 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 150.60 |
Agios Pharmaceuticals' (AGIO) posts encouraging results for the second quarter. The company is enrolling participants across five pivotal studies evaluating the lead drug Pyrukynd.
Nektar (NKTR) reports dismal second-quarter 2022 results. The company's operating expenses increased due to restructuring expenses of $106.0 million incurred during the quarter.
Novavax (NVAX) closed the most recent trading day at $61.93, moving +1.34% from the previous trading session.